APRI (AST to Platelet Ratio Index) Calculator


Estimate liver fibrosis from AST and platelet count.

Enter the values and click Calculate.

Inserisci i valori:
U/L
U/L

Use your laboratory's upper limit (often 40 U/L).

Risultati:

About this calculator

APRI was developed in chronic hepatitis C and is used in many settings, including hepatitis B and C programmes where elastography is not available.

What you need

  • AST in U/L from the liver panel.
  • The laboratory's upper limit of normal for AST in U/L; 40 is the default, but use the printed limit from the report because assays differ.
  • Platelet count in x10^9/L (= x10^3/microlitre), typically 150 to 400.

Formula

APRI = [(AST / upper limit of normal for AST) / platelet count (10⁹/L)] x 100.

How to read the result

ResultCategoryMeaning
0 to 0.4999LowSignificant fibrosis is unlikely (below 0.5).
0.5 to 1.4999IndeterminateNeither rules in nor rules out significant fibrosis.
1.5 to 1.9999Significant fibrosis likely1.5 or more suggests significant fibrosis (Wai 2003).
2 or moreCirrhosis likely2.0 or more suggests cirrhosis (WHO hepatitis B and C guidance).

Worked example

AST 80 U/L with upper limit 40 and platelets 200: (80 / 40) / 200 x 100 = 1.0.

Common mistakes

  • Leaving the upper limit at 40 when the laboratory reports a different one; the ratio shifts with the limit.
  • Applying hepatitis-C cut-offs mechanically to other liver diseases.
  • Reading a raised AST as fibrosis when it may come from muscle injury, alcohol or medication.

Limitations

Moderate accuracy only. Cut-offs were set in hepatitis C and differ between guidelines. AST can be raised for reasons other than fibrosis.

Frequently asked questions

When is APRI useful?

Where elastography or biopsy is not readily available, such as hepatitis B and C programmes in resource-limited settings; WHO guidance uses it there.

APRI or FIB-4?

Both are screening tools with moderate accuracy; many pathways start with FIB-4 because it adds age and ALT, and use APRI as a second opinion.

Reference

  • Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38(2):518-526. doi:10.1053/jhep.2003.50346
  • World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. 2015.

Disclaimer. Medical information only. This calculator is an educational aid for clinicians and students. It does not give medical advice, diagnosis or treatment, and it does not replace clinical judgment. Check results against the original source and local protocols before using them in patient care.